Get the insights you need on the Coronaviruses from Clarivate Analytics
Access the world’s leading research and late-breaking news on this health emergency with this collection of tools and resources from Clarivate Analytics.
Search for:
NMEs, notable line extensions and worldwide approvals: A comprehensive look at the year’s new drugs & biologics, 2017
“The year’s new drugs & biologics, 2017” presents an in-depth look at 113 of the new drugs and biologics that were approved or launched for the first time globally in 2017. Fifty-two of the new arrivals reached their first markets worldwide in 2017. Seven of the new launches were first-in-class agents, meaning the first drug […]
The results are in: Announcing this year’s Top 100 Global Innovators.
The Derwent Top 100 Global Innovators 2018-19 report has been published today. This is the latest annual report which aims to identify the leading innovative organizations from around the globe, to celebrate their achievements and contributions to enriching the world through innovation, and to identify key trends and changes in the innovation ecosphere. Derwent has […]
Your Unitary Patent Checklist: Five steps to take to prepare
Earlier this year, we provided an overview of the Unitary Patent (UP) and how it will affect patent owners and practitioners. Now, with the announcement that the Unified Patent Court (UPC) sunrise period is adjusted to begin March 1, 2023, IP professionals are likely wondering what they can do to prepare. To help you get […]
How to get drugs reimbursed in Singapore, ranking as the world’s most efficient healthcare system
This second blog in our series on health technology assessments (HTAs) in the Asia-Pacific (APAC) region examines the process by which HTAs are conducted in Singapore and what this means for affordable and timely market access of new and innovative treatments. If you missed the first blog in our series, check out “What’s driving oncology […]
World’s most innovative organizations named for 2022 [Report]
We put a spotlight on the world’s most innovative organizations in our latest report. Analyze our list by country, region and sector today.
How your IP and R&D teams can strategize and prioritize for the evolution of SEPs
Much of the focus on standard essential patents (SEPs) over the past decades has centered on the telecommunications industry. With technologies converging and industries overlapping, telecoms impact nearly every business today in some way. Furthermore, standards-centric industries are constantly expanding and as a result many companies’ IP and R&D departments are spending more and more […]
Is the FDA’s carrot and stick approach to pediatric drugs working?
It has been five years since the Pediatric Research Equity Act (PREA) and the Best Pharmaceuticals for Children Act (BPCA) were made permanent laws by the U.S. Congress through passage of the Food and Drug Administration Safety and Innovation Act (FDASIA) in July 2012.
Predictive analytics yield smarter pharma portfolio decisions
Collecting competitive data isn’t the problem; most biopharma companies are drowning in it. But making sense of the data, using it to predict likely shifts in the competitive landscape and drive decisions can be a challenge. While forecasting drug timelines and success rates are critical to inform investment and R&D decisions, the standard approach has […]
Mainland China’s NRDL: The expensive yet priceless ticket to market access
Recent updates in the NRDL highlight Mainland China’s improving market access and reimbursement environment for innovative therapies. However, this comes at the cost of heavy price cuts that manufacturers must offer in exchange for NRDL inclusion. Are these price cuts worth gaining market access in Mainland China? What other trends have emerged from the recent […]